Showing results (551-560 of 1,378) with videos related to
Sort By:
Pageof 138
Immunology|May 1, 1990
Oligodendrocyte susceptibility to injury by T-cell perforinN J Scolding, J Jones, D A Compston, et al.Immunology|April 1, 1997
Mechanisms of complement resistance induced by non-lethal complement attack and by growth arrestK J Marchbank, C W van den Berg, B P MorganJournal of Virological Methods|February 1, 1984
A comparison of Rubazyme-M and MACRIA for the detection of rubella-specific IgMJ M Best, S J Palmer, P Morgan-Capner, et al.Immunology|February 26, 2000
Production and functional characterization of a soluble recombinant form of mouse CD59N K Rushmere, C W Van Den Berg, B P MorganJournal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Development of adenovirus vectors encoding rat complement regulators for use in therapy in rodent models of inflammatory diseasesY McGrath, G W Wilkinson, O B Spiller, et al.Anaesthesia|February 4, 2003
Alveolar recruitment strategy improves arterial oxygenation after cardiopulmonary bypassB A Claxton, P Morgan, H McKeague, et al.Epidemiology and Infection|August 1, 1995
Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategyN J Gay, L M Hesketh, P Morgan-Capner, et al.Archives of Neurology|February 1, 1977
Acetazolamide-induced interference with primidone absorption. Case reports and metabolic studiesG B Syversen, J P Morgan, M Weintraub, et al.Immunology|May 1, 1995
Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attackK J Marchbank, B P Morgan, C W van den BergImmunology|April 1, 1994
Presence of a dysfunctional form of CD59 on a CD59+ subclone of the U937 cell lineC W van den Berg, O M Williams, B P MorganPageof 138